{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:35:16Z","timestamp":1776850516696,"version":"3.51.2"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dev Pharmacol Ther"],"abstract":"<jats:p>The single-dose pharmacokinetics of dexamethasone were\nstudied in 7 extremely low birth weight infants of mean\n(\u00b1 SD) gestational age 25.6 \u00b10.5 weeks suffering bronchopulmonary\ndysplasia. A mean peak dexamethasone concentration\nof 250.5 \u00b1 70.7 ng\/ml was obtained following an intravenous\nbolus dose (0.369 \u00b1 0.04 mg\/kg dexamethasone) of\ndexamethasone sodium phosphate. Dexamethasone was measured\nin plasma by HPLC. Mean clearance (0.143 \u00b1 0.028\nlitres\/kg\/h) was approximately half that reported previously in\nchildren and adults, while the half-life (9.26 \u00b1 3.34 h) was 2-\nto 3-fold longer than in these patients. The volume of distribution\n(1.9 \u00b1 0.483 litres\/kg) was larger than reported in a previous\nstudy in adults, but was similar to that determined in \npediatric and adult patients in another study.<\/jats:p>","DOI":"10.1159\/000457564","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T17:08:44Z","timestamp":1502471324000},"page":"205-210","source":"Crossref","is-referenced-by-count":33,"title":["Pharmacokinetics of Dexamethasone\nfollowing Single-Dose Intravenous\nAdministration to Extremely Low Birth\nWeight Infants"],"prefix":"10.1159","author":[{"given":"Bruce","family":"Charles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Steer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2017,8,11]]},"container-title":["Developmental Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000457564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:34:55Z","timestamp":1776846895000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000457564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000457564","archive":["Portico"],"relation":{},"ISSN":["0379-8305","2504-2505"],"issn-type":[{"value":"0379-8305","type":"print"},{"value":"2504-2505","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]}}}